Finance

Lists
4164:TADAWUL
Al Nahdi Medical Company SJSC
SAR 90.70
+0.72%
(+0.65) 1D
Nov 4, 3:10:09 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 4164...
Open
SAR 90.05
High
SAR 91.60
Low
SAR 90.05
Mkt. cap
11.79B
Avg. vol.
119.93K
Volume
103.42K
Dividend
6.17%
Quarterly dividend
SAR 1.40
Ex-dividend date
Aug 16, 2026
P/E ratio
14.76
52-wk high
SAR 116.70
52-wk low
SAR 81.10
EPS
SAR 6.14
Shares outstanding
80.35M
No. of employees
6K
Open
SAR 90.05
High
SAR 91.60
Low
SAR 90.05
Mkt. cap
11.79B
Avg. vol.
119.93K
Volume
103.42K
Dividend
6.17%
Quarterly dividend
SAR 1.40
Ex-dividend date
Aug 16, 2026
P/E ratio
14.76
52-wk high
SAR 116.70
52-wk low
SAR 81.10
EPS
SAR 6.14
Shares outstanding
80.35M
No. of employees
6K
News stories
From web sources and news partners
About Al Nahdi Medical Company SJSC
CEO-
Employees6.15K
Founded1986
Headquarters-
SectorDrug
Industry-
Websitenahdi.sa
Previous reportsAll values in SAR
Loading Previous Earnings...
Revenue
Net income
All values in SAR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.46B
2.59B
2.79B
2.67B
Cost of goods sold
1.52B
1.75B
1.81B
1.67B
Cost of revenue
1.52B
1.75B
1.81B
1.67B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
756.61M
630.42M
734.17M
766.43M
Operating expense
753.00M
633.76M
727.99M
761.77M
Total operating expenses
2.27B
2.38B
2.53B
2.43B
Operating income
187.57M
207.85M
259.74M
245.86M
Other non operating income
63.00
-52.76M
210.15K
344.39K
EBT including unusual items
166.46M
188.39M
239.22M
222.53M
EBT excluding unusual items
166.46M
187.90M
239.00M
217.61M
Income tax expense
5.21M
12.47M
3.54M
7.30M
Effective tax rate
3.13%
6.62%
1.48%
3.28%
Other operating expenses
-3.61M
3.34M
-6.18M
-4.66M
Net income
161.25M
175.92M
235.68M
215.23M
Net profit margin
6.55%
6.79%
8.43%
8.05%
Earnings per share
-
-
-
-
Interest and investment income
16.28M
22.55M
14.37M
7.79M
Interest expense
-37.39M
-1.12M
-35.32M
-36.38M
Net interest expenses
-21.11M
21.44M
-20.95M
-28.59M
Depreciation and amortization charges
-
-
-
-
EBITDA
261.10M
282.78M
334.35M
320.97M
Gain or loss from assets sale
-74.66K
-411.45K
-60.72K
-155.21K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps